Press Releases

Home / Investor Relations / Press Releases

Language

Category

Year

2017-09-20 08:46 Boule Diagnostics appoints new CFO Regulatory

Christina Rubenhag has been appointed Chief Financial Officer (CFO) of Boule Diagnostics and member of the Group Management Team. She succeeds Fredrik Alpsten who, as communicated earlier, will leave Boule to assume a position at another company. Christina...

2017-08-31 13:33 Boule Diagnostics – Number of shares and votes Regulatory

The incentive program for senior management and key individuals implemented at the Annual General Meeting held on May 13, 2014 entitles, through the exercise of options, the holders to subscribe for new shares in the company during the second half of...

2017-08-25 09:07 Boule Diagnostics AB (publ) Interim report January – June 2017 Regulatory

Stable sales following a strong first quarter, restructuring expenses burden profitability Actions to increase efficiency and profitability During the quarter, the company has completed several processes to increase efficiency and future profitability...

2017-08-23 11:16 Boule Diagnostics changes the publication date of interim report January - June 2017

Boule Diagnostics AB has decided to publish the interim report for the first six months of 2017 earlier than previously announced. The new publishing date is Friday, August 25 at 08:45. For further information, please contact: Fredrik Dalborg, CEO and...

2017-07-31 08:35 Boule Diagnostics – Number of shares and votes Regulatory

2017-05-22 08:45 Boule Diagnostics strengthens the management team

Boule Diagnostics is taking the next step in the development and strengthening of the management. As of June 1, Debbie Herrera and Fredrik Ekdahl will be joining the group management team. Debbie Herrera has been employed by Boule in Florida since early...

2017-05-16 09:16 Boule Diagnostics optimizes the manufacturing structure – shuts down the Chinese production facility Regulatory

Boule’s process efficiency program continues. As a result of this, the manufacturing of instruments will in the future be concentrated to the Swedish production facility. A decision has therefor been made during the second quarter of 2017 to discontinue...

2017-05-12 08:45 Bulletin from Annual General Meeting in Boule Diagnostics AB on May 11, 2017

The Annual General Meeting (the ”AGM”) decided to adopt the balance sheet and income statement, consolidated income and balance sheet for 2016. Furthermore, it was decided that a dividend of SEK 1.40 per share will be distributed and remaining result...

2017-05-11 13:00 Boule Diagnostics AB (publ) interim report January-March 2017 Regulatory

Instrument sales remain strong Quarter January-March 2017 Tender won in India Boule has won yet another public tender in India for 100 hematology systems in total. The systems were delivered during the quarter. The systems have been installed at blood...

2017-03-27 08:45 Boule Diagnostics increases focus on Indonesia – Receives grant from Swedfund

Boule Diagnostics sales in Indonesia, the fourth most densely populated country in the world with over 250 million inhabitants, have grown in recent years. Indonesia was Boule’s fifth largest market in 2016. Sales rose by 167% compared to the previous...

2017-03-17 08:45 Boule Diagnostics wins strategic tender Regulatory

Boule Diagnostics AB has won the tender to supply hematology instruments to the Västra Götaland Region in Sweden. The tender is for around 40 of the new Swelab Alfa Plus generation instruments and includes service, consumables and spare parts. Installation...

2017-02-16 08:45 Boule Diagnostics AB (publ) Year-end report 2016 Regulatory

Continued sales success Quarter October-December 2016 Net sales amounted to SEK 105.8 million (88.4), up 19.7 percent. Adjusted for the change in the USD and EUR exchange rates, this corresponds to an increase of 14.4 percent. Cash flow from operating...

2017-02-15 17:30 Boule Diagnostics presents new financial targets and dividend policy Regulatory

The Boule Diagnostics board has resolved to revise the company's financial targets and to adjust the dividend policy. The financial targets that will apply effective today are: The board has also resolved to adjust the dividend policy. For more information...

2017-01-18 11:15 Boule Diagnostics wins another tender in India Regulatory

Boule Diagnostics AB has won a public tender to blood banks in India for around 100 Medonic-systems in total. The systems will be delivered in first quarter 2017. The procuring authorities are Centre of Medicine Store and Distribution (CMSD) Lucknow...

2017-01-17 15:00 Boule Diagnostics – Changes to nominations committee ahead of the 2017 AGM Regulatory

Following publication of the Boule nomination committee ahead of the 2017 Annual General Meeting, a change to its composition of members has been made due to the change in ownership at Boule. Staffan Persson who represented Zimbrine Holding B.V. has left...

2017-01-10 08:30 New CEO and Group President at Boule Diagnostics Regulatory

Ernst Westman is resigning as CEO and Group President of Boule Diagnostics at the end of first quarter 2017. The board has named Fredrik Dalborg as new CEO and Group President effective 3 April. “After 23 years as CEO and good growth for Boule, I am...

2016-12-09 08:30 Boule Diagnostics wins tenders in Egypt Regulatory

Boule Diagnostics AB has won two major public tenders in Egypt for around 200 hematology systems in total. Successive deliveries of the instruments will start in December 2016. The final shipment is expected to be made in the first half of 2017. The procuring...

2016-11-09 08:30 Boule Diagnostics AB (publ) interim report January-September 2016 Regulatory

Contract in USA Boule has signed an agreement with Novant Health Systems ("NHS") to be the main supplier of three-part hematology systems. NHS is a renowned not-for-profit network of doctors' offices, outpatient clinics and hospitals. The network comprises...

2016-08-26 08:45 Boule Diagnostics awarded contract in USA Regulatory

Via its US subsidiary, Boule Diagnostics has signed an agreement with Novant Health Systems in the United States, as the primary vendor for three part differential hematology systems. Novant Health System is a highly reputable not-for-profit integrated...

2016-08-01 12:00 Boule Diagnostics AB (publ) interim report January-June 2016 Regulatory

Record sales and increased profit Quarter April-June 2016 Interim period January-June 2016 Tender won in India In early May, Boule won a tender for 136 Medonic systems in the state of Uttar Pradesh in North India, in partnership with its Indian distributor...

Previous Next